Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Renal Cell 26Kidney Neoplasms 21Melanoma 20Leukemia 17Leukemia, Myeloid, Chronic-Phase 15Multiple Myeloma 12Lymphoma 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10Neoplasms, Plasma Cell 8Lymphoma, Follicular 7Pancreatic Neoplasms 6Waldenstrom Macroglobulinemia 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Non-Hodgkin 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Myeloid, Accelerated Phase 5Leukemia, Lymphocytic, Chronic, B-Cell 5Burkitt Lymphoma 5Neoplasms 4Lymphoma, Mantle-Cell 4Lung Neoplasms 4Leukemia, Myeloid, Acute 4Immunoglobulin Light-chain Amyloidosis 4Blast Crisis 4Urinary Bladder Neoplasms 3Primary Myelofibrosis 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Myeloproliferative Disorders 3

Interventions

Ifosfamide 17Methotrexate 16Doxorubicin 14Filgrastim 13Etoposide 12Cisplatin 12Cyclophosphamide 10Gemcitabine 9Leucovorin 8Sirolimus 6Carboplatin 6Topotecan 5Irinotecan 5Granulocyte Colony-Stimulating Factor 5Temozolomide 4Sorafenib 4Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Docetaxel 4trimetrexate glucuronate 3temsirolimus 3dinutuximab 3cixutumumab 3apatinib 3Vincristine 3Specimen Handling 3Oxaliplatin 3Nivolumab 3Magnetic Resonance Spectroscopy 3Imatinib Mesylate 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Osteosarcoma × Interferon-alpha × Clear all
NCT00504140 2012-08-02

Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma

M.D. Anderson Cancer Center

Phase 2 Completed
30 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡